Loading…
InterCure Ltd. is projected to rise to $1.07 by 2027, a +15% move from its current price of $0.9279. INCR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.9039 | $0.9285 | $0.9537 | +0.06% |
| May 30 | $0.8945 | $0.9291 | $0.965 | +0.13% |
| May 31 | $0.8875 | $0.9296 | $0.9738 | +0.19% |
| Jun 1 | $0.8817 | $0.9302 | $0.9815 | +0.25% |
| Jun 2 | $0.8766 | $0.9308 | $0.9883 | +0.31% |
| Jun 3 | $0.8722 | $0.9314 | $0.9946 | +0.38% |
| Jun 4 | $0.8682 | $0.932 | $1.00 | +0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8682 | $0.932 | $1.00 | +0.44% |
| Week 2 | $0.8467 | $0.9361 | $1.03 | +0.88% |
| Week 3 | $0.8315 | $0.9402 | $1.06 | +1.32% |
| Week 4 | $0.8194 | $0.9443 | $1.09 | +1.77% |
| Week 5 | $0.8093 | $0.9484 | $1.11 | +2.21% |
| Week 6 | $0.8007 | $0.9526 | $1.13 | +2.66% |
| Week 7 | $0.7931 | $0.9568 | $1.15 | +3.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector.
The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
InterCure Ltd. currently trades at $0.8778 per share. The market cap stands at $48M, and the stock is ranked 4615 by market capitalization.
The current price sits against a market position that reflects modest liquidity and investor interest as captured by the market cap and rank. The forecast path through 2050 suggests multi-year upside, with average prices rising from 2026 through 2050 and sizable max targets.
A major floor 25.7% below — a decisive break under it would weaken the trend.
The nearest floor, 19.3% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 12.9% above — clearing it would confirm fresh momentum.
Key INCR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INCR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.8828 | Buy | $0.8902 | Buy |
| MA 10 | $0.8544 | Buy | $0.8691 | Buy |
| MA 20 | $0.8477 | Buy | $0.8509 | Buy |
| MA 50 | $0.8052 | Buy | $0.8413 | Buy |
| MA 100 | $0.8509 | Buy | $0.9105 | Buy |
| MA 200 | $1.16 | Sell | $1.08 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.56 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 204.20 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 10.61 | Buy |
| Bollinger %B (20,2) | 1.12 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | 0.05 | Buy |
| Ultimate (7,14,28) | 80.30 | Sell |
| Momentum (10) | 0.12 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 0.91 | Buy |
| ADX (14) | 14.22 | Neutral |
| ATR (14) | 0.02 | Info |
The 14-day RSI is 60, and the sentiment is BULLISH. The SMA50 is $0.7998 and the SMA200 is $1.16. The stock has key support at $0.749 and resistance at $0.908. The latest 30-day range runs from $0.7345 to $1.05.
Annualized volatility is 50%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.73 | $0.9279 | $1.29 | 0% | Neutral | |
| $0.8485 | $1.07 | $1.42 | +15% | Neutral | |
| $0.8887 | $1.15 | $1.59 | +24% | Bullish | |
| $0.8073 | $1.07 | $1.51 | +15% | Neutral | |
| $0.8372 | $1.13 | $1.64 | +22% | Bullish | |
| $1.03 | $1.41 | $2.09 | +52% | Bullish | |
| $1.08 | $1.51 | $2.29 | +63% | Bullish | |
| $1.15 | $1.63 | $2.50 | +75% | Bullish | |
| $1.18 | $1.69 | $2.65 | +83% | Bullish | |
| $1.11 | $1.62 | $2.57 | +75% | Bullish | |
| $1.57 | $2.44 | $4.11 | +163% | Bullish | |
| $2.65 | $4.62 | $8.50 | +398% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.73 | $0.9279 | $1.09 | +0.00% |
| June 2026 | $0.8122 | $0.9535 | $1.15 | +2.76% |
| July 2026 | $0.8299 | $0.9823 | $1.20 | +3.02% |
| August 2026 | $0.8123 | $0.9677 | $1.19 | -1.49% |
| September 2026 | $0.8035 | $0.9623 | $1.19 | -0.55% |
| October 2026 | $0.8303 | $0.9994 | $1.25 | +3.85% |
| November 2026 | $0.8437 | $1.02 | $1.28 | +2.05% |
| December 2026 | $0.8366 | $1.02 | $1.29 | -0.43% |
Click any year to see its month-by-month INCR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect INCR to range from $0.73 to $1.29 through 2026. The $0.9279 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The INCR price prediction for 2027 points to an average of $1.07 (low $0.8485, high $1.42) — a potential gain of +15% on today's $0.9279. Price action looks broadly range-bound.
In 2028, INCR is projected to trade between $0.8887 and $1.59, averaging $1.15 — a potential gain of +24% from today's $0.9279. That is up +8% on the projected 2027 average. Buyers look set to stay in control over this stretch.
InterCure Ltd.'s 2029 outlook centres on $1.07, within a $0.8073 to $1.51 range. That is -7% versus the projected 2028 average. That marks a +15% change versus current levels. Price action looks broadly range-bound.
By 2030, INCR could reach as high as $1.64, with a base case around $1.13 and support toward $0.8372 — roughly +22% from $0.9279. Buyers look set to stay in control over this stretch.
Expect INCR to range from $1.03 to $2.09 through 2031. The $1.41 average target implies a +52% move from current prices. That is up +25% on the projected 2030 average. Momentum favours further upside here.
The INCR price prediction for 2032 points to an average of $1.51 (low $1.08, high $2.29) — a potential gain of +63% on today's $0.9279. Buyers look set to stay in control over this stretch.
In 2033, INCR is projected to trade between $1.15 and $2.50, averaging $1.63 — a potential gain of +75% from today's $0.9279. That is up +7% on the projected 2032 average. Momentum favours further upside here.
InterCure Ltd.'s 2034 outlook centres on $1.69, within a $1.18 to $2.65 range. That is up +4% on the projected 2033 average. That marks a +83% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, INCR could reach as high as $2.57, with a base case around $1.62 and support toward $1.11 — roughly +75% from $0.9279. Momentum favours further upside here.
Expect INCR to range from $1.57 to $4.11 through 2040. The $2.44 average target implies a +163% move from current prices. That is up +50% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The INCR price prediction for 2050 points to an average of $4.62 (low $2.65, high $8.50) — a potential gain of +398% on today's $0.9279. Momentum favours further upside here.
Investing $1,000 in INCR today (≈ 1,077.702339 INCR) could be worth
$4,983.19
+$3,983.19 (+398%) by 2050 · US Dollar
Based on the average projected INCR price of $4.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INCRwould be worth at today's price.
$1,000 invested in INCR on May 27, 2025 (≈ 641.025665 INCR) would be worth
$594.81
-$405.19 (-40.5%) today · 0.59× · US Dollar
Based on a INCR entry price of $1.56 vs. today's $0.9279.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.855 | $1,085.26 | +8.5% |
| 1 month ago | $0.899 | $1,032.15 | +3.2% |
| 3 months ago | $0.802 | $1,156.98 | +15.7% |
| 6 months ago | $1.34 | $693.5 | -30.7% |
| 1 year ago | $1.56 | $594.81 | -40.5% |
| All time (5.0y) ago | $8 | $115.99 | -88.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INCR forecast.
Our base-case forecast reaches $1.90 around 2040.
Implied market cap at $1.90: $103.89M
The multi-year forecast shows a bullish tilt in the later years. The 2030 forecast has an average price of $1.05 with a max of $1.52 and an ROI of 19.3%; sentiment for 2030 is NEUTRAL.
The 2040 forecast shows an average price of $2.18 with a max of $3.68 and an ROI of 148.4%; sentiment is BULLISH.
The 2050 forecast shows an average price of $4.09 with a max of $7.54 and an ROI of 366.1%; sentiment is BULLISH.
Overall, the long-term outlook points to meaningful upside from the current level, but outcomes are not guaranteed and depend on market conditions and execution.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.05 with a minimum of $0.7755 and a maximum of $1.52, with an ROI of 19.3% and sentiment NEUTRAL.
The forecast outlines upside potential, with 2040 average price $2.18 and 2050 average price $4.09, corresponding to ROIs of 148.4% and 366.1% respectively. Early years show Neutral to Bullish sentiment, and these are estimates, not guarantees.
Yes—the 2050 max forecast is $7.54, which implies the possibility of passing $5 in that horizon.
Current price is $0.8778 and market cap is $48M.
The 14-day RSI is 60 with a BULLISH sentiment. The SMA50 is $0.7998 and the SMA200 is $1.16. Support is at $0.749, resistance at $0.908, and the 30-day range is $0.7345–$1.05. Annualized volatility is 50%.
InterCure Ltd. Community Discussion
0Share your InterCure Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.